Skip to main
CARL

Carlsmed Inc (CARL) Stock Forecast & Price Target

Carlsmed Inc (CARL) Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 80%
Buy 20%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Carlsmed is a rapidly growing medical technology company with a unique AI-enabled platform and increasing surgeon adoption, leading to potential revenue growth. With reported positive clinical outcomes and a strong focus on profitability, this company is expected to continue its double-digit growth trajectory. However, changes in reimbursement and competition may have an impact on their stock price.

Bears say

Carlsmed is a medical technology company specializing in personalized solutions for spine surgery, but its lack of profitability and reliance on Medicare as its primary payer could hinder its growth potential. While its aprevo technology has shown promise for improving patient outcomes and surgical efficiency, there is competition in the market and Carlsmed's limited patent protection may leave it vulnerable. Furthermore, despite potential upside from surgeon adoption and reimbursement changes, it remains to be seen if Carlsmed can reach profitability with its current projected revenue and spending.

Carlsmed Inc (CARL) has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 80% of analysts recommend a Strong Buy, 20% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Carlsmed Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Carlsmed Inc (CARL) Forecast

Analysts have given Carlsmed Inc (CARL) a Strong Buy based on their latest research and market trends.

According to 5 analysts, Carlsmed Inc (CARL) has a Strong Buy consensus rating as of Aug 8, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $19, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $19, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Carlsmed Inc (CARL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.